VentriPoint Diagnostics (TSXV:VPT) FCF Margin % : -2,419.51% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is VentriPoint Diagnostics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. VentriPoint Diagnostics's Free Cash Flow for the three months ended in Dec. 2023 was C$-0.99 Mil. VentriPoint Diagnostics's Revenue for the three months ended in Dec. 2023 was C$0.04 Mil. Therefore, VentriPoint Diagnostics's FCF Margin % for the quarter that ended in Dec. 2023 was -2,419.51%.

As of today, VentriPoint Diagnostics's current FCF Yield % is -11.03%.

The historical rank and industry rank for VentriPoint Diagnostics's FCF Margin % or its related term are showing as below:

TSXV:VPT' s FCF Margin % Range Over the Past 10 Years
Min: -7971.79 Med: -3066.67 Max: -1009.38
Current: -7763.27

During the past 13 years, the highest FCF Margin % of VentriPoint Diagnostics was -1009.38%. The lowest was -7971.79%. And the median was -3066.67%.

TSXV:VPT's FCF Margin % is ranked worse than
97.83% of 829 companies
in the Medical Devices & Instruments industry
Industry Median: -7.24 vs TSXV:VPT: -7763.27

VentriPoint Diagnostics FCF Margin % Historical Data

The historical data trend for VentriPoint Diagnostics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics FCF Margin % Chart

VentriPoint Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-2,960.49

-3,066.67

-6,083.82

-7,763.27

VentriPoint Diagnostics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-3,732.14	-22,425.00	-23,625.00	-	-2,419.51

Competitive Comparison of VentriPoint Diagnostics's FCF Margin %

For the Medical Devices subindustry, VentriPoint Diagnostics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VentriPoint Diagnostics's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's FCF Margin % falls into.

VentriPoint Diagnostics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

VentriPoint Diagnostics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-3.804	/	0.049
	=	-7,763.27 %

VentriPoint Diagnostics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.992	/	0.041
	=	-2,419.51 %

VentriPoint Diagnostics FCF Margin % Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

VentriPoint Diagnostics (TSXV:VPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (TSXV:VPT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

VPTDF:USA 5V7:Germany

Address

18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4

Website

https://www.ventripoint.com

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

Executives

Robert Hodgkinson

Director

VentriPoint Diagnostics (TSXV:VPT) Headlines

No Headlines